Abstract Details

Title NeuroMeasures™: Implementation of a Web-Based Real-Time Quality Metric Tool to Improve Provider Practices in an Epilepsy Clinic

Topic Epilepsy/Clinical Neurophysiology (EEG)

Presentation(s) P2 - Poster Session 2 (11:45 AM-12:45 PM)

Poster/Presentation
Number 10-002

Objective Our objective was to assess whether the implementation of NeuroMeasures™, a web-based application developed to identify unmet ��ɫ�� - Epilepsy Quality Measures (AAN-EQM), can facilitate meeting AAN-EQM at the point-of-care.

Background Despite the importance to incorporate quality measures in daily practice, implementation of EQM remains challenging in clinical practices.

Design/Methods This prospective study was conducted at the Detroit Medical Center/Wayne State University as per institutional review board guidelines. All adults (≥ 18 years of age) with a diagnosis of seizures or epilepsy were included in the study. Exclusion criteria incuded non-English-speaking patients and patients with severe cognitive disabilities. Patients completed two sets of surveys on a web-based application that obtained information based on the AAN-EQM and validated surveys focusing on quality of life (QoL), depression and anxiety which were then scored by the application. Two document tools were automatically generated based on patient responses: patient education document and a healthcare provider document which prompted discussion and possible intervention of unmet quality measures at the time of the office visit. We retrospectively analyzed healthcare provider responses and applied established EQM equations to our datasets.

Results Two hundred unique adult epilepsy clinic patients consented to volunteer. The average time to complete surveys was seven minutes. More than 50% of the surveys were completed by people aged 18-44 (58%) and women (57%) and nearly 70% of the survey responders identified themselves as Black. Overall percentages of adherence of EQM are as follows: counseling for women of childbearing potential with epilepsy (94%), patient with intractable epilepsy referral to a comprehensive epilepsy center (85%), quality of life assessment with people with epilepsy (86%), improvement of quality-of-life measurements (70%), and depression and anxiety screening (90%).

Conclusions A web-based, point-of-care application helped our providers to identify and address unmet EQM in real-time while also creating opportunities for patient education.

Authors/Disclosures
Maryam J. Syed, MBBS (Wayne State University School of Medicine) PRESENTER	Dr. Syed has nothing to disclose.
Rohit A. Marawar, MD, FAAN (Wayne State University - Detroit Medical Center)	Dr. Marawar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz Pharmaceuticals. Dr. Marawar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SK Pharma. Dr. Marawar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Xenon. Dr. Marawar has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurelis.
Maysaa M. Basha, MD, FAAN (Wayne State University, Detroit Medical Center)	Dr. Basha has nothing to disclose.
Deepti Zutshi, MD, FAAN (Wayne State University School of Medicine)	Dr. Zutshi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Xenon pharmaceuticals. An immediate family member of Dr. Zutshi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Scientific. Dr. Zutshi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aucta Pharmaceuticals. Dr. Zutshi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Aucta.

��ɫ����

��ɫ����

��ɫ��

��ɫ��